Early Screening and Identification for Panvascular Diseases

Recruiting

• Conditions: Panvascular Diseases

• Registration Number: NCT05485870
• Lead Sponsor: Beijing Tiantan Hospital

Brief Summary

Identify the pathogenic factors involved in the occurrence and development of panvascular disease and its pathogenesis.

Detailed Description

Identify the pathogenic factors involved in the occurrence and development of panvascular disease and its pathogenesis by a multi-omics study.

Study Timeline

• Study Start: 2022-07-01
• Status Verified: 2022-08
• Study First Submitted: 2022-08-01
• Study First Submitted QC: 2022-08-01
• Last Update Submitted: 2022-08-01
• Study First Posted: 2022-08-03
• Last Update Posted: 2022-08-03
• Primary Completion: 2024-07-31
• Study Completion: 2024-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• 1. Patients with panvascular diseases; 2. Patients or guardians who agreed to join the study; 3. Patients who can complete the relevant examinations involved in this study;

Exclusion Criteria

• patients with coagulation dysfunction.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Any new stroke events	Up to 48 months	Incidence of any new ischemic or hemorrhagic stroke

Trial Locations

Locations (1)

Beijing Tiantan Hospital Capital Medical University; 🇨🇳 Beijing, Beijing, China